drugset
drugset / Trial / NCT06748144

IO Vancomycin Spine

NCT06748144 ↗

Phase 2/3 Not yet recruiting 30 enrolled The Methodist Hospital Research Institute
RandomizedParallel-groupSingle-blindPrevention

Summary

The goal of this research is to learn if injecting the antibiotic vancomycin directly into the bone marrow (intraosseous) or IO) during a lumbar (spinal) fusion surgery, is as effective or better than the standard method of giving it vancomycin through a vein (intravenous) or IV) during lumbar fusion surgery.

Timeline

Start
2026-05
Primary completion
2027-04
Completion
2030-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vancomycin Other / unclassified 15 mg/kg Other
Subject Vancomycin Other / unclassified 500 mg Other

Indications

No indication recorded.